A panel of outside advisers to the U.S. Food and Drug Administration (FDA) voted Thursday to let specialized pharmacies produce and sell four peptide treatments the agency banned three years ago.
Jul 24, 2026
0
12
Between 2018 and 2024, those who worked in construction and trades made up approximately one-third of deaths from opioid toxicity in Ontario where occupation was known, according to a report released this week by the Ontario ...
Jul 24, 2026
0
8
A volunteer was injected Friday with the first dose of a rapidly developed vaccine targeting the Bundibugyo strain of Ebola driving a deadly outbreak in the Democratic Republic of Congo, Oxford University said.
Jul 24, 2026
0
4
Scientists at the Icahn School of Medicine at Mount Sinai have uncovered the first high-resolution structure of NBCn2, a brain protein linked to epilepsy, autism spectrum disorder and other neurological conditions, and developed ...
Jul 23, 2026
0
20
Glowing skin, deeper sleep, stronger muscles, an alert mind? Such are the enticing promises of peptides, an increasingly buzzy class of substances touted by influencers and celebrities as the key to an optimized life.
Jul 23, 2026
0
6
A panel of federal health advisers on Thursday narrowly recommended easing access to several peptides popular with wellness influencers and celebrities, despite warnings from government scientists that the chemicals haven't ...
Jul 23, 2026
0
7
Antimicrobial resistance is one of the world's most alarming public health challenges because multidrug-resistant (MDR) gram-negative bacteria increasingly render even last-line antibiotics ineffective, leading to substantially ...
Jul 23, 2026
0
5
Sleep is known to be essential for survival, as it allows both humans and other animals to rest, while the brain consolidates memories and clears out metabolic waste products. For many people worldwide, however, falling asleep ...
Curcumin, berberine and other plant-derived compounds have long attracted scientific interest because of their anti-inflammatory and anticancer properties. A new study by researchers from Wroclaw Medical University and the ...
Jul 22, 2026
0
151
The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, a study published by The BMJ finds. ...
Jul 22, 2026
0
30
